Jubilant launches Remdesivir in India for treatment of COVID-19

August 04, 2020 13:09

Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment through its distribution network.

Jubilant's 24-hour helpline will enhance access to JUBI-R during these pandemic times where timely access to the drug may prove critical to treatment outcomes.

In order to increase its accessibility to patients below the poverty line and to frontline paramedical staff, Jubilant Bhartia Foundation -- a not-for-profit organisation of Jubilant Group -- is launching programmes aimed at the distribution of the drug.

In May, Jubilant entered into a non-exclusive licensing agreement with Gilead Sciences Inc that granted it the right to register, manufacture and sell investigational drug Remdesivir in 127 countries including India.

Remdesivir is the only anti-viral drug that has received emergency use authorisation by the US Food and Drug Administration for treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe disease.

« Back to LIVE

TOP STORIES

Set for emotional homecoming, can Rishabh Pant & Co. overcome Sunrisers test?

He walked on crutches in one of his first public appearances at Feroz Shah Kotla last year, but when an emotional Rishabh Pant walks out as captain of Delhi Capitals, he will need to put on his 'out of box' thinking cap to stop a...

Crude realisation: Oil's slick grip threatens corporate margins, profits

Corporate margins and profits in India remain vulnerable to changes in crude oil prices in the international market. Historical quarterly data from listed companies (excluding banks, finance and insurance, oil and gas, and power...

Phase 1: 40% turnout till 1 pm; stray violence reported in Bengal

Minor EVM glitches were reported at some booths in Tamil Nadu, Arunachal Pradesh, Andaman and Nicobar Islands and Assam.

Anything can happen to Kejriwal in jail: AAP

Aam Aadmi Party Rajya Sabha MP Sanjay Singh Friday reiterated his party's allegation that a deep conspiracy is being hatched against Delhi Chief Minister Arvind Kejriwal and anything can happen with him in prison.

No damage to Iran's nuclear sites amid Israel attack: IAEA

In a statement released on Friday, the United Nations Atomic Watchdog said it is monitoring the situation very closely.